6
total announcements
VIVIMEDLAB.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹53 Cr
P/E (Forward)
0.5
EPS (TTM)
₹-2.93
52W Low
₹4.90
52W High
₹27.99
Beta
0.58
Price / Book
-1.1
Revenue (TTM)
₹109 Cr
Gross Margin
52.46%
Operating Margin
-27.12%
Vivimed Labs Ltd
Vivimed Labs Ltd has intimated the 8th meeting of the Committee of Creditors (CoC) under the Corporate Insolvency Resolution Process (CIRP) scheduled to be held on September 29, 2026.
Vivimed Labs Ltd
Vivimed Labs Ltd has sought an extension of time by three months to convene its Annual General Meeting (AGM) for the Financial Year 2025-26.
Vivimed Labs Ltd
Vivimed Labs Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter and half year ended September 30, 2026.
Vivimed Labs Ltd
Vivimed Labs Ltd has announced the 6th meeting of the Committee of Creditors (CoC) under the Corporate Insolvency Resolution Process (CIRP) scheduled for August 18, 2026.
Vivimed Labs Ltd
Vivimed Labs Ltd has re-lodged transfer requests for physical shares with the Registrar and Share Transfer Agent, Aarthi Consultants Pvt Ltd, as per SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated 30th January 2026.
Vivimed Labs Ltd
Vivimed Labs Ltd has published its financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations. The results were published in newspapers 'Financial Express' and 'Hosadigantha' on July 19, 2026.